Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.
about
Antioxidants, inflammation and cardiovascular diseaseThe biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patientsThe relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort studyExpression and regulation of soluble epoxide hydrolase in adipose tissueEffects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseasesPharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.Connexins in vascular physiology and pathology.Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study.Enzamin ameliorates adipose tissue inflammation with impaired adipocytokine expression and insulin resistance in db/db mice.CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.Change in body fat mass is independently associated with executive functions in older women: a secondary analysis of a 12-month randomized controlled trialEpicardial and pericardial fat volume correlate with the severity of coronary artery stenosis.Dietary calcium and dairy modulation of oxidative stress and mortality in aP2-agouti and wild-type miceImpact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI studySerotonin Improves High Fat Diet Induced Obesity in Mice.Diet-induced obesity severely impairs myelinated aortic baroreceptor reflex responsesAlzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectivesImpacts of the Great East Japan Earthquake on diabetic patients.Exploring metabolic dysfunction in chronic kidney disease.Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis.Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation StudyRegional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.The underlying mechanisms for development of hypertension in the metabolic syndromeAlveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice.Serum adipokine concentrations in dogs with naturally occurring pituitary-dependent hyperadrenocorticism.Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study.Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets.PPARgamma in the endothelium regulates metabolic responses to high-fat diet in micePediatric obstructive sleep apnea: complications, management, and long-term outcomes.Non alcoholic fatty liver disease and metabolic syndrome.Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease.A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese populationeNOS, metabolic syndrome and cardiovascular disease.Immune and inflammatory mechanisms of atherosclerosis (*)Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding.Metabolic alterations in different stages of hypertension in an apparently healthy nigerian populationThe emerging role of the endocannabinoid system in cardiovascular disease.Relevance of a Hypersaline Sodium-Rich Naturally Sparkling Mineral Water to the Protection against Metabolic Syndrome Induction in Fructose-Fed Sprague-Dawley Rats: A Biochemical, Metabolic, and Redox Approach.Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis.
P2860
Q26823009-746EF99C-52AC-4DB7-B03F-CB9ED9C13B84Q26862601-90571187-19EA-4BD5-A9D0-54A17C1016A4Q28394961-A5E2590A-A756-4290-B1D9-A6E53640F860Q28395245-B9928BB6-4BD4-4C61-A8CC-B4296D78D637Q28744267-46DDA583-1E1B-48EF-BBFA-FA4B37429737Q30366778-7303D986-3F6D-478C-BE57-DB7A0886ACEEQ30437099-EC16E00E-FA17-4842-8EBC-E203214F34E4Q33918445-87DA32D7-B98C-4934-9824-2C74244C4E50Q33932855-EFBCD359-3191-4221-907F-71C8E4BE59F4Q34127227-3A9DF14D-1035-41EE-890A-055A976A224AQ34193651-57EE7C61-784E-4498-B8E9-29C32BDF9BA6Q34544582-29084990-566C-4229-92C7-F58D90FA8DE9Q34925607-C2F604F8-0D54-41CE-B1AF-E8547FFEF63DQ35670769-E1A73A0C-7CC2-4D72-A91E-94F2D712CBCAQ35792277-960C215B-E082-4730-9EE4-05779842BAB9Q35894079-6E330FF2-59D0-42BD-B3AE-80706483DD9CQ35994115-FF809DDA-3EA3-4122-A0D6-5733545CB611Q36026292-08153BF3-F066-4B71-BD78-4025966E1892Q36082267-9263E2B3-12FB-467B-A4DB-D0A70965A54EQ36123347-95F470FE-4FB9-4F2A-B538-514CCF4B7697Q36196157-DEDE8D31-7540-49AD-8763-EFEEE32275A4Q36351005-B03BEDBB-6A51-4669-AC14-1941E3779EBAQ36510256-F9302307-17D0-4755-8884-6AB4AFF81630Q36585178-112B0FC6-56EF-427D-B363-4CFA197452E1Q36619374-3933DB83-CDE4-4D19-80ED-6D369B5F40C9Q36873308-FE3FA435-BFCD-4AC4-A30A-CE6E0E66B7E9Q36935873-8C7AC706-C1D4-44BF-86BF-F882AD52E7BEQ37031065-0F249343-7267-4B74-9BE1-FF9B681028F1Q37036060-0FB69829-ABE8-4B76-8589-7053661E58AFQ37077182-F9E854D4-E9E3-4F63-94BC-42B5EF264EA0Q37078311-FFADB4CE-ED2D-41D2-938F-F721853DD249Q37275149-115F1531-7E64-4A80-A947-C737CEE34695Q37308797-3BB1F788-CAEC-4C0E-93A5-4FF838A4B9BBQ37317509-41FD7C56-B6B0-4551-89EF-879AAAF56A13Q37325024-97A4A8CB-11C7-460E-A939-AE30037CABC5Q37344131-8DC552D1-9C7F-4763-9929-E8FFD5301B48Q37382773-BA1B770B-BB87-4D56-8254-004FD8270A65Q37439386-64889BE1-FADB-4CB9-8A52-36AD6DACB8B3Q37615131-1E8E32E8-B73D-48E7-8463-E2B9CF78A552Q37690126-3F708418-5731-4C0A-B678-E04A6C63C8D3
P2860
Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Adiposity and cardiovascular d ...... humoral and neuronal signals.
@en
type
label
Adiposity and cardiovascular d ...... humoral and neuronal signals.
@en
prefLabel
Adiposity and cardiovascular d ...... humoral and neuronal signals.
@en
P2093
P1433
P1476
Adiposity and cardiovascular d ...... humoral and neuronal signals.
@en
P2093
Hideki Katagiri
Tetsuya Yamada
Yoshitomo Oka
P356
10.1161/CIRCRESAHA.107.151621
P577
2007-07-01T00:00:00Z